Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ProPhase Labs (PRPH) Receivables: 2010-2025

Historic Receivables for ProPhase Labs (PRPH) over the last 15 years, with Sep 2025 value amounting to $3.3 million.

  • ProPhase Labs' Receivables fell 89.81% to $3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $63.6 million, marking a year-over-year decrease of 54.91%. This contributed to the annual value of $20.1 million for FY2024, which is 49.45% down from last year.
  • As of Q3 2025, ProPhase Labs' Receivables stood at $3.3 million, which was down 83.65% from $20.1 million recorded in Q2 2025.
  • In the past 5 years, ProPhase Labs' Receivables ranged from a high of $64.7 million in Q4 2021 and a low of $3.3 million during Q3 2025.
  • Moreover, its 3-year median value for Receivables was $33.5 million (2024), whereas its average is $29.1 million.
  • In the last 5 years, ProPhase Labs' Receivables surged by 1,368.74% in 2021 and then crashed by 89.81% in 2025.
  • ProPhase Labs' Receivables (Quarterly) stood at $64.7 million in 2021, then slumped by 33.82% to $42.8 million in 2022, then decreased by 7.34% to $39.7 million in 2023, then tumbled by 49.45% to $20.1 million in 2024, then crashed by 89.81% to $3.3 million in 2025.
  • Its last three reported values are $3.3 million in Q3 2025, $20.1 million for Q2 2025, and $20.2 million during Q1 2025.